VERTEX PHARMACEUTICAL

The current price of VX1 is 367.90 EUR — it has decreased by 0.92% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange VERTEX PHARMACEUTICAL stocks are traded under the ticker VX1.

VERTEX PHARMACEUTICAL is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.

VX1 stock is 1.14% volatile and has beta coefficient of 0.94. Check out the list of the most volatile stocks — is VERTEX PHARMACEUTICAL there?

One year price forecast for VERTEX PHARMACEUTICAL has a max estimate of 540.65 EUR and a min estimate of 306.10 EUR.

VX1 earnings for the last quarter are 3.86 EUR whereas the estimation was 3.72 EUR which accounts for 3.72% surprise. Estimated earnings for the next quarter are 3.68 EUR. See more details about VERTEX PHARMACEUTICAL earnings.

VERTEX PHARMACEUTICAL revenue for the last quarter amounts to ‪2.35 B‬ EUR despite the estimated figure of ‪2.37 B‬ EUR. In the next quarter revenue is expected to reach ‪2.28 B‬ EUR.

Yes, you can track VERTEX PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.

VX1 net income for the last quarter is ‪877.74 M‬ EUR, while the quarter before that showed ‪979.39 M‬ EUR of net income which accounts for −10.38% change. Track more VERTEX PHARMACEUTICAL financial stats to get the full picture.

Today VERTEX PHARMACEUTICAL has the market capitalization of ‪95.41 B‬, it has decreased by 2.06% over the last week.

No, VX1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, VX1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VERTEX PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.

VX1 reached its all-time high on Dec 11, 2008 with the price of 1124624.00 EUR, and its all-time low was 4.20 EUR and was reached on Apr 13, 2004.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has ‪5.40 K‬ employees. See our rating of the largest employees — is VERTEX PHARMACEUTICAL on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VERTEX PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VERTEX PHARMACEUTICAL stock shows the buy signal. See more of VERTEX PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on VERTEX PHARMACEUTICAL future price: according to them, VX1 price has a max estimate of 540.66 EUR and a min estimate of 306.12 EUR. Read a more detailed VERTEX PHARMACEUTICAL forecast: see what analysts think of VERTEX PHARMACEUTICAL and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VERTEX PHARMACEUTICAL EBITDA is ‪3.58 B‬ EUR, and current EBITDA margin is 45.32%. See more stats in VERTEX PHARMACEUTICAL financial statements.